About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5937 record(s)
Req # A-2022-000927
The latest Periodic Benefit-Risk Evaluation Report (PBRER) submitted to Health Canada for product Tegsedi, marketed in Canada by Akcea Therapeutics Inc.Organization: Health Canada
July 2024
Req # A-2022-001098
Documents showing how many inspections of tobacco manufacturers have taken place, excluding Japan Tobacco International (JTI) and Rothmans Benson & Hedges (RBH), in the past 5 years, broken down by year and the number of charges that have been…Organization: Health Canada
July 2024
Req # A-2022-001379
Records from July 1, 2022 to Feb. 1, 2023 concerning CannTrust Holdings Inc./Phoena Holdings Inc.Organization: Health Canada
July 2024
Req # A-2023-000030
All records pertaining to the application by Hash Guild Inc. of Toronto, Ontario to Health Canada for a Marijuana microprocessing license; and the granting of such license by Health Canada on or about June 25, 2021.Organization: Health Canada
July 2024
Req # A-2023-000582
The initial cover letter(s) indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-03-15 for the medicinal ingredient liraglutide…Organization: Health Canada
July 2024
Req # A-2023-000638
The initial cover letter(s) indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient mesalazine.…Organization: Health Canada
July 2024
Req # A-2023-001051
With regard to the webpage on Health Canada’s website currently titled “Report a side effect to a vaccine: Consumers” (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffectcanada/adverse-reaction-reporting/vaccine/consumer.…Organization: Health Canada
July 2024
Req # A-2023-001089
Health Canada issued a recall of the following Pine Sol product: https://recalls-rappels.canada.ca/en/alert-recall/pine-solr-scented-multi-surface-cleaners-recalled-due-risk-exposure-bacteria. Among the reports received by Health Canada after the…Organization: Health Canada
July 2024
Req # A-2023-001135
SUMMARY MONTHLY SAFETY REPORT #4. The date when this report was received; the date when the review was completed and by whom; findings including: newly identified signals, both validated and invalidated, as identified during this reporting period…Organization: Health Canada
July 2024
Req # A-2023-001139
SUMMARY MONTHLY SAFETY REPORT #8. The date when this report was received; the date when the review was completed and by whom; findings including: newly identified signals, both validated and invalidated, as identified during this reporting period…Organization: Health Canada
July 2024